Skip to main content
AFJK logo

AFJK · Aimei Health Technology Co., Ltd. · Metrics

Track AFJK — free
$12.20 +0.10 (+0.79%) At close · Oct 21
Market Cap
$37.71M
Shares
3.17M
Volume · Oct 20 1300 Avg daily vol (3M) 21.69K

AFJK metrics

49 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.10
Market cap
$37.71M

Price action

20 metrics
Price change (1W)
-3.2%
Price change (30D)
+0.8%
Price change (3M)
+0.8%
Price change (6M)
-70.8%
Price change (YTD)
-81.1%
Price change (1Y)
+6.1%
Trailing year
Price change (5Y)
—
52-week high
$88.50
52-week low
$8.00
Change from 52-week high
-86.3%
Change from 52-week low
+51.3%
Annualized volatility
1,083.1%
Annualized volatility (3M)
24.8%
Beta
-1.9
RSI (14D)
44.4
Price vs SMA 50
-0.6%
Price vs SMA 200
-61.8%
Avg volume (3M)
21,686
Relative volume
0.1
Average dollar volume
$262,774

Company

3 metrics
Sector
Financial Services
Industry
Shell Companies
Shares outstanding
3.17M

Valuation

12 metrics
P / E (TTM)
92.9
Trailing earnings · reciprocal yield 1.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
1.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$635,073
Net income (TTM)
$412,432
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
0.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1.91

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
-119.6%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-48.3%
Year over year · fewer shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
3.3%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
$12.53M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$370,854
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
21
13F filer change QoQ
0
Institutional ownership
151.5%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
25.7%
Active holders' share change QoQ
0.0%
Holder tenure
9.4
Price vs estimated holder cost
+156.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
31 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1979005 CUSIP G01341109